357 related articles for article (PubMed ID: 17440068)
1. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
2. TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma.
Zhao J; Chen J; Lu B; Dong L; Wang H; Bi C; Wu G; Guo H; Wu M; Guo Y
Cancer Res; 2008 Jun; 68(11):4133-41. PubMed ID: 18519672
[TBL] [Abstract][Full Text] [Related]
3. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y
Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960
[TBL] [Abstract][Full Text] [Related]
4. TIP30 deficiency increases susceptibility to tumorigenesis.
Ito M; Jiang C; Krumm K; Zhang X; Pecha J; Zhao J; Guo Y; Roeder RG; Xiao H
Cancer Res; 2003 Dec; 63(24):8763-7. PubMed ID: 14695192
[TBL] [Abstract][Full Text] [Related]
5. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
6. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
7. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
[TBL] [Abstract][Full Text] [Related]
9. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
13. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
16. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
17. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
18. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
19. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
[TBL] [Abstract][Full Text] [Related]
20. Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.
Zhu M; Yin F; Fan X; Jing W; Chen R; Liu L; Zhang L; Liu Y; Liang Y; Bu F; Tong X; Zheng H; Zhao J; Guo Y
Oncogene; 2015 Mar; 34(11):1420-31. PubMed ID: 24681951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]